| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,642 |
2,798 |
$1.17M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,931 |
3,872 |
$1.03M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,778 |
1,309 |
$736K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,085 |
2,905 |
$573K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,807 |
1,995 |
$299K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,760 |
1,452 |
$268K |
| 80053 |
Comprehensive metabolic panel |
4,590 |
3,889 |
$223K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
233 |
176 |
$213K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
816 |
748 |
$154K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,102 |
982 |
$146K |
| 87631 |
|
805 |
735 |
$133K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,403 |
1,186 |
$122K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,095 |
2,685 |
$105K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,151 |
1,063 |
$98K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,170 |
997 |
$92K |
| J3490 |
Unclassified drugs |
1,474 |
855 |
$85K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
561 |
463 |
$85K |
| 71046 |
Radiologic examination, chest; 2 views |
1,241 |
798 |
$83K |
| 36415 |
Collection of venous blood by venipuncture |
6,470 |
5,227 |
$73K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
828 |
772 |
$55K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,574 |
1,356 |
$54K |
| 85027 |
|
1,997 |
1,658 |
$53K |
| 84484 |
|
1,247 |
1,027 |
$51K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
980 |
872 |
$50K |
| 83605 |
|
1,134 |
964 |
$49K |
| 71045 |
Radiologic examination, chest; single view |
793 |
542 |
$48K |
| 83690 |
|
1,494 |
1,283 |
$46K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,232 |
1,001 |
$45K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
693 |
515 |
$43K |
| 97161 |
|
425 |
406 |
$41K |
| 80306 |
|
656 |
582 |
$39K |
| 83735 |
|
1,452 |
1,218 |
$39K |
| 84703 |
|
847 |
794 |
$37K |
| 85007 |
|
2,038 |
1,700 |
$31K |
| 83880 |
|
231 |
196 |
$28K |
| J2704 |
Injection, propofol, 10 mg |
232 |
189 |
$21K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
68 |
65 |
$18K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
356 |
303 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
189 |
165 |
$17K |
| 70450 |
Computed tomography, head or brain; without contrast material |
38 |
26 |
$17K |
| J7050 |
Infusion, normal saline solution, 250 cc |
314 |
250 |
$16K |
| A9270 |
Non-covered item or service |
8,451 |
3,932 |
$15K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
529 |
467 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
365 |
313 |
$14K |
| 81001 |
|
1,269 |
1,131 |
$13K |
| 97162 |
|
92 |
83 |
$12K |
| 80061 |
Lipid panel |
118 |
111 |
$10K |
| 81003 |
|
1,051 |
954 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
257 |
229 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
259 |
226 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
182 |
168 |
$5K |
| 84439 |
|
107 |
99 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
68 |
65 |
$4K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
15 |
14 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
30 |
26 |
$3K |
| 73630 |
|
29 |
25 |
$3K |
| 82550 |
|
128 |
105 |
$2K |
| 72100 |
|
13 |
12 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$2K |
| 94664 |
|
29 |
25 |
$2K |
| 73610 |
|
20 |
16 |
$2K |
| 73030 |
|
16 |
12 |
$2K |
| 85610 |
|
101 |
91 |
$2K |
| 82553 |
|
61 |
51 |
$1K |
| 85378 |
|
30 |
27 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
13 |
12 |
$375.37 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$331.95 |
| 90686 |
|
26 |
26 |
$277.33 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
27 |
27 |
$8.20 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
139 |
105 |
$0.00 |